MicroRNA Control of Hepatocyte–Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177581 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Kurt Sartorius und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine and Molecular Sciences, University of KwaZulu-Natal (UKZN), Durban 4041, South Africa. Hauptthemen laut MEDLINE: MicroRNAs, Tumor Microenvironment, Liver Neoplasms, Hepatocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic hepatitis B virus (CHB) infection remains a major cause of hepatocellular carcinoma (HCC), yet the premalignant microenvironment that links to HBV-associated HCC (HBV-HCC) is still poorly defined. This review synthesizes evidence that HBV-infected hepatocytes function as signaling hubs that, through microRNA (miRNA)-regulated crosstalk with Kupffer cells, liver sinusoidal endothelial cells, hepatic stellate cells and cancer-associated fibroblasts (CAFs), progressively remodel the liver from an antiviral tissue into a premalignant and early tumor microenvironment. Across the HBV-HCC continuum, a core set of dysregulated miRNAs, including miR-21, miR-29a/b, miR-122, miR-146a, miR-155, miR-200a, miR-126, miR-210 and the miR-130/301 family, coordinates transition from innate antiviral responses to HSC activation, extracellular matrix deposition, mechanotransduction, angiogenesis, chronic inflammation and cancer-associated CAF programing. By mapping these stage-specific miRNA networks onto acute infection, CHB, early fibrogenesis, advanced fibrosis and CAF-rich dysplastic states, the review reframes HBV-HCC pathogenesis as a sequence of miRNA-guided hepatocyte–stromal states rather than a purely hepatocyte-intrinsic process. This perspective suggests that composite, cell-type-resolved miRNA signatures in serum or liver tissue could serve as biomarkers for identifying CHB patients who are entering a premalignant microenvironment before conventional surveillance markers become abnormal. It further highlights miRNA hubs that couple antiviral, fibrogenic, angiogenic and CAF-associated signaling as potential therapeutic targets for reprograming the HBV-driven premalignant microenvironment, with the long-term goal of intercepting HBV-HCC development at earlier, microenvironmentally defined stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Laboratory Medicine and Molecular Sciences, University of KwaZulu-Natal (UKZN), Durban 4041, South Africa.
- Africa Hepatobiliary Cancer Consortium (AHPBCC), Mayo Clinic, Jacksonville, MN 55902, USA.
- Hepatitis Virus Diversity Research Unit, University of the Witwatersrand, Johannesburg 2000, South Africa.
ORCID-Profile: Kurt Sartorius, Anna Kramvis, Anil Chuturgoon
Zitieren
APA
Sartorius, K., Kramvis, A., & Chuturgoon, A. (2026). MicroRNA Control of Hepatocyte–Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177581
Vancouver
Sartorius K, Kramvis A, Chuturgoon A. MicroRNA Control of Hepatocyte–Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177581
BibTeX
@article{Sartorius2026,
author = {Sartorius, Kurt and Kramvis, Anna and Chuturgoon, Anil},
title = {MicroRNA Control of Hepatocyte–Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177581}
}
EUVIMED